论文信息 - Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia - 字舞流文

Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

M. Konopleva | H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | N. Daver | S. O'brien | M. Rytting | R. Garris | Deborah M. Thomas | Rebecca E. Garris